ResearcherAmplified Sciences IncActive in the last 2 years

Daniel A. Sheik

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-4252-7850; OpenAlex author ID A5085762758; NIH RePORTER profile ID 15608438. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 1
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2023: 1 paper · 2024: 1 grant

Papers 1

Addressing the unmet clinical need for low-volume assays in early diagnosis of pancreatic cancer. Co-author DOI 10.3389/fgstr.2023.1258998 ↗

Grants 1

Translating a Novel Assay for Risk Stratification of Potentially Malignant Pancreatic Cystic Lesions R43CA277913 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Vincent Jo Davisson · 1 shared paper, 2023 · strength 0.18
- Paper Addressing the unmet clinical need for low-volume assays in early diagnosis of pancreatic cancer. DOI 10.3389/fgstr.2023.1258998 ↗
Kimberly Saunders Kirkwood · 1 shared paper, 2023 · strength 0.18
- Paper Addressing the unmet clinical need for low-volume assays in early diagnosis of pancreatic cancer. DOI 10.3389/fgstr.2023.1258998 ↗
Charles S. Craik · 1 shared paper, 2023 · strength 0.18
- Paper Addressing the unmet clinical need for low-volume assays in early diagnosis of pancreatic cancer. DOI 10.3389/fgstr.2023.1258998 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.